Corporate Science, Innovation and Firm Value
AbstractIt can be observed that many R&D performing firms produce scientific knowledge and disclose research outcomes in scientific journals. At the micro-level, prior work identified several potential benefits of such a strategy like superior access to informal information networks or the opportunity of recruiting the best PhD graduates. However, scientific research is costly and subject to considerable uncertainty with respect to the outcomes, and the disclosure may lead to spillover effects that decrease the ability of firms to generate returns of their R&D investments. Overall, it remains unclear if and under what conditions science-oriented strategies are beneficial for firms. We address this gap and examine the impact of scientific activities on the firm’s market value using accounting data for US firms from Compustat and matched patent and scientific publication data. We find evidence for a positive impact of scientific publication stocks on the firm value beyond the effects of R&D, patent stocks and patent quality.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by ULB -- Universite Libre de Bruxelles in its series iCite Working Papers with number 2013-006.
Length: 34 p.
Date of creation:
Date of revision:
R&D; Industrial science; Market value; Tobin’s Q; Knowledge disclosure; Econometric evidence;
Other versions of this item:
You can help add them by filling out this form.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Benoit Pauwels).
If references are entirely missing, you can add them using this form.